Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
AXSM

Updated 10/6/2026, 9:41 AM ET.

AXSM

Axsome Therapeutics, Inc.

Sale$2,086,500

Jacobson Mark L.

Chief Operating Officer

10,000 shat $208.65Filed Sep 3, 7:09 PM ET
Filing
AXSM

Axsome Therapeutics, Inc.

Sale$10,538,305

TABUTEAU HERRIOT

Chief Executive Officer, Director, 10% owner

49,664 shat $212.19Filed Aug 7, 7:00 PM ET
Filing

Read from public SEC filings. Not financial advice.